Article
Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.
Experimental and Clinical Pharmacopsychology, Clinic for Affective Disorders and General Psychiatry, University Hospital of Psychiatry Zurich, Switzerland.
The International Journal of Neuropsychopharmacology (impact factor:
4.58).
06/2012;
DOI:10.1017/S1461145712000624
pp.1-13
Source: PubMed
- Citations (10)
-
Cited In (0)
-
Article: A shift of paradigm: from noradrenergic to dopaminergic modulation of learning?
[show abstract] [hide abstract]
ABSTRACT: d-Amphetamine coupled with behavioral training has been effective for improving functional recovery after stroke. d-amphetamine acts on multiple brain transmitter systems, but the recovery enhancing effect has been attributed to its noradrenergic actions. Another potent modulator of learning is dopamine, which may also enhance stroke recovery in humans. Based on data from previous studies of our group, we compared the learning enhancing effects of d-amphetamine with a more selective dopaminergic substance (levodopa) in identical protocols. Using a prospective, randomized, double-blind, placebo-controlled design, we had taught 60 male healthy subjects a miniature lexicon of 50 concrete nouns over the course of five consecutive training days using an associative learning principle. Subjects had received either d-amphetamine (0.25 mg/kg), levodopa/carbidopa (fixed dose of 100/25 mg), or placebo 90 min prior to training on each of the 5 days. Novel word learning was significantly enhanced in both the d-amphetamine and levodopa groups as compared to the placebo group. The learning superiority was maintained at the two re-assessments (1 week and 1 month post training). Both d-amphetamine and levodopa are thus potent drugs in enhancing learning in humans. We here discuss why the efficiency of both d-amphetamine and levodopa may be related to dopaminergic rather than noradrenergic actions.Journal of the Neurological Sciences 11/2006; 248(1-2):42-7. · 2.35 Impact Factor -
Article: Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
[show abstract] [hide abstract]
ABSTRACT: Decreased dopaminergic function has been postulated to underlie cocaine addiction. To examine the possibility that dysfunction of brain regions subserved by the dopamine system could promote cocaine self-administration, positron emission tomography and a dual-tracer approach was used to examine dopamine D2 receptor availability and regional brain glucose metabolism in cocaine abusers. When compared to normal controls, cocaine abusers showed significant decreases in dopamine D2 receptor availability which persisted 3-4 months after detoxification. Decreases in dopamine D2 receptor availability were associated with decreased metabolism in several regions of the frontal lobes, most markedly orbito-frontal cortex and cingulate gyri. Dopamine dysregulation of these brain areas which are involved in the channeling of drive and affect could lead to loss of control resulting in compulsive drug-taking behavior.Synapse 07/1993; 14(2):169-77. · 2.94 Impact Factor -
Relationship of striatal dopamine synthesis capacity to age and cognition. . Journal of Neuroscience Breitenstein C 28 14320-14328.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
29 dependent cocaine users
47 stimulant-naive controls
amphetamine co-use
blue-yellow discrimination
cerebral dopamine alterations
chronic cocaine users
Cognitive performance
colour vision discrimination
colour vision disorder
dependent cocaine users
dopaminergic stimulants
drug-induced changes
frequent blue-yellow colour vision disorders
higher colour confusion indices
Inferior performance
intact colour vision
memory performance
Occasional cocaine
serotonergic stimulant MDMA
Specific blue-yellow colour vision impairment